|
AAPS Conference on Translational Biomarkers for Accelerating Drug Development: From Preclinical to Clinical
May 6-7, 2009
Sheraton Inner Harbor
Baltimore, MD
Goals and Objectives
The Biomarker market will reach $12.5 billion by 2012 according to an April, 2008 article in R&D Directions. Biomarkers are being discovered and used for drug target discovery as well as decision-making during development, and are also being used clinically for disease diagnosis and treatment. The FDA has published its Critical Path Initiative and is working with experts from the academians and industry to facilitate biomarker qualification for drug development and clinical application. In short, biomarkers are an important area for drug development and disease treatment.
The objectives of this workshop are to:
- Provide pharmaceutical scientists, academicians and regulatory scientists with a dialogue opportunity and educational highlights of biomarkers application in drug development and disease diagnosis/prognosis and treatment;
- provide an overview of how biomarkers are being utilized in drug discovery, translating preclinical lead to clinical trials, and for bedside applications;
- provide an educational opportunity for understanding how biomarkers are used pre-clinically and clinically and the challenges for translating preclinical biomarkers to clinical application;
- use various diseases, including cancers, dyslipidemia, osteroporosis, and organ transplantation, as examples to illustrate recent success and challenges ahead in application of biomarker to drug development and disease treatment;
- cover biomarkers from genomics to proteomics to imaging, and showcase the diversity and breadth of biomarkers application in drug development;
- enable the attendees to take away the message of how biomarkers could be interpreted mechanistically with mathematics for analyzing the exposure/response relationship to guide treatments for better clinical outcomes; and
- update the regulatory perspectives concerning biomarker qualifications.
The attendees will have a better appreciation of how biomarkers at all stages are interrelated as well as their specific roles in the successful application to drug discovery/development and clinical outcomes.
The poster abstract submission website is now open!
Log onto http://abstracts.aapspharmaceutica.com/Biomarkers/login.asp to submit your abstracts for this workshop. The submission deadline is January 30, 2009. If you have questions or need assistance as you submit your abstracts please contact abstracts@aaps.org.
|
